Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-15.79M
↓ 173% below average
Average (7y)
$-5.78M
Historical baseline
Range
High:$-1.57M
Low:$-15.79M
CAGR
+39.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-15.79M | -69.3% |
| 2023 | $-9.32M | -16.0% |
| 2022 | $-8.04M | -74.9% |
| 2021 | $-4.59M | -147.0% |
| 2020 | $-1.86M | +45.6% |
| 2019 | $-3.42M | -102.9% |
| 2018 | $-1.69M | -7.4% |
| 2017 | $-1.57M | - |